Loading stock data…
IEX
$214.93-2.92 (-1.34%)
Market ClosedLast close May 1
IDEX Corporation, together with its subsidiaries, provides applied solutions in the United States, North America, Europe, Asia, and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
IDEX Corporation in the Industrials sector is trading at $214.93. The stock is currently near its 52-week high of $223.85, remaining 18.9% above its 200-day moving average. Technical signals show neutral RSI of 62 and bullish MACD crossover, explaining why IEX maintains its current momentum and trend strength. The Whystock Score of 65/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Neutral momentum (RSI 62) — price action in range
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$214.93
Potential Downside
37.1%
Whystock Fair Value$135.11
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus14 analysts
Buy
Mean target$235.93+9.8%
Range$210.00 – $260.00
Fundamentals
IDEX Corporation, together with its subsidiaries, provides applied solutions in the United States, North America, Europe, Asia, and internationally. It operates through three segments: Health & Science Technologies (HST), Fluid & Metering Technologie...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$15.41B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
32.34
Beta
Defensive asset. Lower volatility than the S&P 500.
0.98
Div Yield
Strong income play. Yield provides a meaningful total return floor.
139.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
11.65%
Volume
Today's trading volume
509,611
Recent News
IDEX Beats Q1 Earnings Estimates on HST Momentum, Raises View
IEX beats Q1 estimates and raises outlook as strong Health & Science Technologies demand and record orders signal momentum into 2026.
IDEX Q1 Earnings Call Highlights
IDEX (NYSE:IEX) reported first-quarter 2026 results that management said came in above expectations, supported by growth in its targeted “advantage markets” and continued application of the company’s 80/20 operating philosophy. Quarterly performance and orders President and CEO Eric Ashleman said I
IDEX Corporation Q1 2026 Earnings Call Summary
Moby summary of IDEX Corporation's Q1 2026 earnings call
IDEX (IEX) Q1 2026 Earnings Call Transcript
IDEX delivered a strong first quarter and continue to see our growth strategies gain traction as we expand and integrate capabilities in targeted advantaged markets powered by 8020. In the first quarter, IDEX delivered organic sales growth of 5% and adjusted EBITDA margin of 26%, which reflects a margin expansion of 50 basis points year-over-year. Strength was most pronounced in our Health & Science Technologies, or HST segment, where secular drivers continue to fuel growth across high-value applications in data center, semiconductor and space and defense markets.
Idex (IEX) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
The headline numbers for Idex (IEX) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.